SIRT3 and neoplasm: SIRT3 primarily serves as a tumor suppressor by limiting reactive oxygen species levels and antagonizing hypoxia-inducible factor 1-α, which fights against a metabolic switch to aerobic glycolysis (Bell et al., 2011b; Finley et al., 2011; Chalkiadaki and Guarente, 2015).